Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maria del Pilar Guillermo Prieto Eibl"'
Autor:
Jonathan B. Bell, William Jin, Mohammed Z. Goryawala, Gregory A. Azzam, Matthew C. Abramowitz, Tejan Diwanji, Michael E. Ivan, Maria del Pilar Guillermo Prieto Eibl, Macarena I. de la Fuente, Eric A. Mellon
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background Glioblastoma (GBM) cellularity correlates with whole brain spectroscopic MRI (sMRI) generated relative choline to N-Acetyl-Aspartate ratio (rChoNAA) mapping. In recurrent GBM (rGBM), tumor volume (TV) delineation is challenging an
Externí odkaz:
https://doaj.org/article/2c2f8cec5a8147c0872508e5ed6a78f1
Autor:
Hannah Rinehardt, Mahmoud Kassem, Evan Morgan, Marilly Palettas, Julie A. Stephens, Anupama Suresh, Akansha Ganju, Maryam Lustberg, Robert Wesolowski, Sagar Sardesai, Daniel Stover, Jeffrey Vandeusen, Mathew Cherian, Maria del Pilar Guillermo Prieto Eibl, Abdul Miah, Iyad Alnahhas, Pierre Giglio, Vinay K. Puduvalli, Bhuvaneswari Ramaswamy, Nicole Williams, Anne M. Noonan
Publikováno v:
European Journal of Breast Health, Vol 17, Iss 4, Pp 371-377 (2021)
Objective:Leptomeningeal carcinomatosis (LMC), a common complication of advanced malignancies, is associated with high morbidity and mortality, yet diagnosis and treatment decisions remain challenging. This study describes the diagnostic and treatmen
Externí odkaz:
https://doaj.org/article/22c7faaf894846a1b01de6c095b3ff82
Autor:
Ali AlMoamen, Maria del Pilar Guillermo Prieto Eibl, Olimpia Carbunar, Luis Tornes, Kamil Detyniecki
Publikováno v:
Neurology. 99:S46.1-S46
ObjectiveWe describe the case of a patient with an extensive autoimmune response after one dose of pembrolizumab, emphasizing the importance of early recognition of the diverse presentation of autoimmune complications from checkpoint inhibitors.Backg
Autor:
Vinay K. Puduvalli, Pierre Giglio, Maria del Pilar Guillermo Prieto Eibl, Iyad Alnahhas, Appaji Rayi, Shirley Ong
Publikováno v:
Neuro-oncology Advances
Background Glioblastoma remains a deadly brain cancer with dismal prognosis. Genetic alterations, including IDH mutations, 1p19q co-deletion status and MGMT promoter methylation have been proven to be prognostic and predictive to response to treatmen
Autor:
Marilly Palettas, Maria del Pilar Guillermo Prieto Eibl, Bhuvaneswari Ramaswamy, Daniel G. Stover, Mahmoud Kassem, Pierre Giglio, Robert Wesolowski, Jeffrey VanDeusen, Anupama Suresh, Iyad Alnahhas, Akansha Ganju, Hannah Rinehardt, Maryam B. Lustberg, Nicole Williams, Evan Morgan, Mathew Cherian, Vinay K. Puduvalli, Anne M. Noonan, Abdul Miah, Sagar Sardesai, Julie A. Stephens
Publikováno v:
Eur J Breast Health
PurposeLeptomeningeal carcinomatosis (LMC), a common complication of advanced malignancies, is associated with high morbidity and mortality, yet diagnosis and treatment decisions remain challenging. This study describes the diagnostic and treatment m
Autor:
Pierre Giglio, Iyad Alnahhas, Javier Gonzalez, Denise Fabian, Vinay K. Puduvalli, Maria del Pilar Guillermo Prieto Eibl, Joshua D. Palmer, Nikhil Sebastian
Publikováno v:
Cancers, Vol 11, Iss 2, p 174 (2019)
Cancers
Cancers
Glioblastoma (GBM) is the most common primary brain tumor. Despite aggressive treatment, GBM almost always recurs. The current standard-of-care for treatment of newly diagnosed GBM has remained relatively unchanged since 2005: maximal safe resection